Problems in therapy for the hypertensive patient.
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002346:Carotid Sinus / Q000294:innervation; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D004558:Electric Stimulation; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000601:surgery; D006974:Hypertension, Malignant / Q000188:drug therapy; D006977:Hypertension, Renal / Q000188:drug therapy; D007024:Hypotension, Orthostatic / Q000628:therapy; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D009392:Nephrectomy; D008517:Phytotherapy; D010946:Plants, Medicinal; D011187:Posture; D011926:Rauwolfia / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014511:Uremia / Q000150:complications
D000959:Antihypertensive Agents; D004232:Diuretics; D006852:Hydrochlorothiazide; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D005665:Furosemide; D004976:Ethacrynic Acid; D006145:Guanethidine